Rogan says it nonchalantly "maybe because if there is a viable treatment then the EUA is no longer valid" JOE KNEW DAMN WELL the STICK OF DYNAMITE he threw out there. Quoting: John James WON Michigan
This is the WHOLE SHIT SHOW....."IF" the FDA approves Ivermectin for COVID they HAVE TO PULL ALL EUA uses for the FAKE VAXX!!!
$$BILLIONS LOST for the CORRUPT MACHINE
CRIMINALS.....Red State AG's need to start charging the FDA/CDC/NIH leaders with MURDER!!!
[link to www.healio.com (secure)
Ivermectin is a key factor in the alliance’s I-MASK+ protocol for prophylaxis and early treatment of outpatients with COVID-19. In the protocol, those at high risk for COVID-19 infection receive ivermectin at 0.2 mg/kg on day 1 and day 3, and weekly for 4 weeks; those who were exposed to COVID-19 receive the same dose at day 1 and day 3; and both groups receive daily doses of vitamin D3, vitamin C, quercetin, zinc and melatonin. For early outpatients with COVID-19, the protocol calls for one dose of ivermectin at 0.2 mg/kg at day 1 and day 3, along with the same daily vitamins and 325 mg per day of aspirin
[link to journals.lww.com (secure)
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
In a press conference, researchers said that ivermectin is an FDA-approved anti-parasitic drug that has been available for approximately 40 years and previously earned researchers a Nobel Prize.
[link to www.ijidonline.com (secure)
The drugs ivermectin and doxycycline are commonly used in the developing world and have been found to be safe and effective in treating both parasitic and bacterial infections. The drugs are affordable (the full 5-day cost ranges from US$ 0.60 to US$ 1.80 for 5-day ivermectin) and readily available in Bangladesh, and thus are a highly attractive alternative for treating COVID-19 patients. The aim of this study was to investigate the role of ivermectin alone or in combination with doxycycline in the treatment of adult COVID-19 patients presenting with mild symptoms. It was hoped that treatment early in the course of infection would decrease the viral load, shorten the duration of illness, and halt transmission.
• Ivermectin, an FDA-approved anti-parasitic agent, was found to be an inhibitor of SARS-CoV-2 replication in the laboratory.
Ivermectin may be effective for the treatment of early-onset mild COVID-19 in adult patients.
Early viral clearance of SARS-CoV-2 was observed in ivermectin treated patients.
Remission of fever, cough and sore throat did not differ among treatment groups. No severe adverse event was observed.
Larger trials will be needed to confirm these preliminary findings.